Cadre (CDRE) vs Establishment Labs (ESTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Establishment Labs (ESTA) has outperformed Cadre (CDRE) over the past year, gaining 1.6% versus a loss of 26.8%. Over five years, CDRE leads with a +51.0% price change compared with +4.1% for ESTA. Establishment Labs is the larger company by market cap ($2.06 billion vs $1.26 billion), about 1.6 times the size.
Cadre pays a dividend yielding 1.34%, while Establishment Labs does not currently pay one. Cadre converts more of its revenue into profit, with a net margin of 7.2% versus -24.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDRE | ESTA |
|---|---|---|
| Share price | $29.45 | $69.14 |
| Market cap | $1.26B | $2.06B |
| 1-day change | -3.63% | -0.68% |
| YTD return | -27.89% | -5.13% |
| 1-year return | -26.83% | +1.63% |
| 5-year return | +51.03% | +4.11% |
| P/E ratio (TTM) | 32.36 | — |
| Forward P/E | 18.53 | — |
| EPS (TTM) | $0.91 | $-1.27 |
| Dividend yield | 1.34% | 0.00% |
| Annual dividend | $0.395 | $0.00 |
| Revenue (latest FY) | $610.31M | $211.08M |
| Revenue growth (YoY) | +7.53% | +27.14% |
| Net income (latest FY) | $44.14M | $-51.06M |
| Gross margin | 42.54% | 69.32% |
| Operating margin | 11.04% | -18.48% |
| Net margin | 7.23% | -24.19% |
| 52-week high | $48.76 | $97.59 |
| 52-week low | $24.07 | $53.16 |
| Distance from 52-week high | -39.60% | -29.15% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +59.02% | +41.74% |
| Average volume | 464.00K | 411.24K |
| Shares outstanding | 42.92M | 29.82M |
| Employees | 2,533 | 1,004 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ESTA has outperformed CDRE by 28.5 percentage points over the past year.
- Cadre offers a meaningfully higher dividend yield (1.34% vs 0.00%).
- Cadre is more profitable, keeping 7.2 cents of every revenue dollar as net income versus -24.2 cents for Establishment Labs.
- Establishment Labs grew revenue faster in its latest fiscal year (+27.14% vs +7.53%).
About Cadre
CDRE stock →Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.
Health Care · Industrial Specialties · 2,533 employees
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
CDRE vs ESTA FAQ
Which is bigger, Cadre or Establishment Labs?
Establishment Labs (ESTA) is larger, with a market capitalization of $2.06B compared with $1.26B for Cadre (CDRE).
Which stock has performed better over the past year, CDRE or ESTA?
ESTA returned +1.63% over the past 12 months, compared with -26.83% for CDRE (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cadre or Establishment Labs?
Cadre pays a dividend yielding 1.34%, while Establishment Labs does not currently pay a regular dividend.
Are Cadre and Establishment Labs in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.